Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy
Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy
复制标题
DOI：
10.21037/jtd.2019.01.88
复制
发表时间：
2019-03-01
影响因子：
2.5
通讯作者：
Kawaguchi, Tomoya
中科院分区：
文献类型：
--
作者：
Yamamoto, Norio;Watanabe, Tetsuya;Kawaguchi, Tomoya
背景资料：超声（US）引导下经皮穿刺活检是一种有用的诊断技术，检查时间短，可在床旁实时监测。然而，只有少数研究报告胸部病变，而计算机断层扫描（CT）引导活检是建立良好的。比较US和CT引导活检的数据也有限。我们的目的是澄清的有效性和安全性的US引导下活检的胸部病变相邻的胸wall.Methods：我们回顾性纳入连续患者谁接受US或CT引导下经皮活检的胸部病变相邻的胸wall.Methods 2012年4月至2017年12月。临床特征，病变大小，病变胸膜接触弧长度（LPCAL），诊断率，和并发症进行了比较2 groups.Results：本研究纳入61 US引导下和70 CT引导下活检。年龄、性别差异无统计学意义。超声引导组的病变大小和LPCAL显著大于CT引导组（P <40 mm），超声引导组显著高于CT引导组（P=0.009）。超声引导组的并发症发生率（3.3%）明显低于CT引导组（24.3%）（P
Background: Ultrasound (US)-guided percutaneous needle biopsy is a useful diagnostic technique with short examination time and real-time monitoring at the bedside. However, there are only a few studies that report on thoracic lesions, whereas the computed tomography (CT)-guided biopsy is well established. There is also limited data comparing US- and CT-guided biopsy. We aimed to clarify the efficacy and safety of US-guided biopsy for thoracic lesions adjacent to the chest wall.Methods: We retrospectively enrolled consecutive patients who underwent US- or CT-guided percutaneous biopsies for thoracic lesions adjacent to the chest wall between April 2012 and December 2017. Clinical characteristics, lesion size, lesion-pleura contact arc length (LPCAL), diagnostic rate, and complications were compared between the 2 groups.Results: This study enrolled 61 US-guided and 70 CT-guided biopsies. No significant difference was found in age or sex. The lesion size and LPCAL in the US-guided group were significantly larger than those in the CT-guided group (P40 mm was significantly higher in the US-guided group than in the CT-guided group (P=0.009). Complication rates were significantly lower in the US-guided group (3.3%) than in the CT-guided group (24.3%) (P